These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37662292)

  • 1. The ventral tegmental area dopamine to lateral amygdala projection supports cocaine cue associative learning.
    Smith DM; Torregrossa MM
    bioRxiv; 2023 Aug; ():. PubMed ID: 37662292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin Promotes Neuroplastic Changes in the Amygdala Associated with Weakened Cocaine-Cue Memories.
    Rich MT; Huang YH; Torregrossa MM
    J Neurosci; 2020 Feb; 40(6):1344-1354. PubMed ID: 31862855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of mesocorticolimbic dopamine projections initiates cue-induced reinstatement of reward seeking in mice.
    Jing MY; Ding XY; Han X; Zhao TY; Luo MM; Wu N; Li J; Song R
    Acta Pharmacol Sin; 2022 Sep; 43(9):2276-2288. PubMed ID: 35217811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural substrates of cocaine-cue associations that trigger relapse.
    See RE
    Eur J Pharmacol; 2005 Dec; 526(1-3):140-6. PubMed ID: 16253228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fos activation of selective afferents to ventral tegmental area during cue-induced reinstatement of cocaine seeking in rats.
    Mahler SV; Aston-Jones GS
    J Neurosci; 2012 Sep; 32(38):13309-26. PubMed ID: 22993446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemogenetic Manipulations of Ventral Tegmental Area Dopamine Neurons Reveal Multifaceted Roles in Cocaine Abuse.
    Mahler SV; Brodnik ZD; Cox BM; Buchta WC; Bentzley BS; Quintanilla J; Cope ZA; Lin EC; Riedy MD; Scofield MD; Messinger J; Ruiz CM; Riegel AC; España RA; Aston-Jones G
    J Neurosci; 2019 Jan; 39(3):503-518. PubMed ID: 30446532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction.
    Aston-Jones G; Smith RJ; Sartor GC; Moorman DE; Massi L; Tahsili-Fahadan P; Richardson KA
    Brain Res; 2010 Feb; 1314():74-90. PubMed ID: 19815001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D1 or D2 receptor antagonism within the basolateral amygdala differentially alters the acquisition of cocaine-cue associations necessary for cue-induced reinstatement of cocaine-seeking.
    Berglind WJ; Case JM; Parker MP; Fuchs RA; See RE
    Neuroscience; 2006; 137(2):699-706. PubMed ID: 16289883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential role of ventral tegmental area acetylcholine and N-methyl-D-aspartate receptors in cocaine-seeking.
    Solecki W; Wickham RJ; Behrens S; Wang J; Zwerling B; Mason GF; Addy NA
    Neuropharmacology; 2013 Dec; 75():9-18. PubMed ID: 23850572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving.
    Grimm JW; Lu L; Hayashi T; Hope BT; Su TP; Shaham Y
    J Neurosci; 2003 Feb; 23(3):742-7. PubMed ID: 12574402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct effects of ventral tegmental area NMDA and acetylcholine receptor blockade on conditioned reinforcement produced by food-associated cues.
    Wickham RJ; Solecki WB; Nunes EJ; Addy NA
    Neuroscience; 2015 Aug; 301():384-94. PubMed ID: 26093048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enduring resistance to extinction of cocaine-seeking behavior induced by drug-related cues.
    Weiss F; Martin-Fardon R; Ciccocioppo R; Kerr TM; Smith DL; Ben-Shahar O
    Neuropsychopharmacology; 2001 Sep; 25(3):361-72. PubMed ID: 11522464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha
    Solecki WB; Kielbinski M; Bernacka J; Gralec K; Klasa A; Pradel K; Rojek-Sito K; Przewłocki R
    Front Behav Neurosci; 2022; 16():969104. PubMed ID: 35990723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible inactivation of the basolateral amygdala, but not the dorsolateral caudate putamen, attenuates consolidation of cocaine-cue associative learning in a reinstatement model of drug-seeking.
    Gabriele A; See RE
    Eur J Neurosci; 2010 Sep; 32(6):1024-9. PubMed ID: 20796021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cue-evoked cocaine "craving": role of dopamine in the accumbens core.
    Saunders BT; Yager LM; Robinson TE
    J Neurosci; 2013 Aug; 33(35):13989-4000. PubMed ID: 23986236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The L-type calcium channel blocker, isradipine, attenuates cue-induced cocaine-seeking by enhancing dopaminergic activity in the ventral tegmental area to nucleus accumbens pathway.
    Addy NA; Nunes EJ; Hughley SM; Small KM; Baracz SJ; Haight JL; Rajadhyaksha AM
    Neuropsychopharmacology; 2018 Nov; 43(12):2361-2372. PubMed ID: 29773910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An extended amygdala-midbrain circuit controlling cocaine withdrawal-induced anxiety and reinstatement.
    Tian G; Hui M; Macchia D; Derdeyn P; Rogers A; Hubbard E; Liu C; Vasquez JJ; Taniguchi L; Bartas K; Carroll S; Beier KT
    Cell Rep; 2022 May; 39(5):110775. PubMed ID: 35508124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prelimbic to Accumbens Core Pathway Is Recruited in a Dopamine-Dependent Manner to Drive Cued Reinstatement of Cocaine Seeking.
    McGlinchey EM; James MH; Mahler SV; Pantazis C; Aston-Jones G
    J Neurosci; 2016 Aug; 36(33):8700-11. PubMed ID: 27535915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha
    Solecki WB; Kielbinski M; Karwowska K; Zajda K; Wilczkowski M; Rajfur Z; Przewłocki R
    Neuropharmacology; 2019 Nov; 158():107680. PubMed ID: 31247269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiated reinstatement of cocaine-seeking behavior following D-amphetamine infusion into the basolateral amygdala.
    Ledford CC; Fuchs RA; See RE
    Neuropsychopharmacology; 2003 Oct; 28(10):1721-9. PubMed ID: 12865896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.